EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0QXX: Molecular Partners Ord Shs

15 May 2026
LAST:

2.900

CHANGE:
 0.13		OPEN:
2.900		HIGH:
2.900		ASK:
0.000		VOLUME:
4.0K
CHG(%):
4.29		PREV:
3.030		LOW:
2.900		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
15 May 262.9002.9002.9002.9004.0K
14 May 263.0453.0503.0303.0303.0K
13 May 263.0453.0503.0303.0303.0K
12 May 263.1503.1503.1503.150200
11 May 263.1803.1803.1803.180100
08 May 263.2303.2303.2303.230283
07 May 263.2303.2303.2303.230282
06 May 263.3303.3303.3303.330256
05 May 263.3303.3303.3303.330100
04 May 263.3203.3203.3203.3202.0K

PROFILE

Name:Molecular Partners Ord Shs
About:Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
Address:Wagistrasse 14, Schlieren, Switzerland, 8952
Website:https://www.molecularpartners.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:0.97 
Price to Sales:78.92 
Price to Book:1.50 
Return on Assets:-0.27 
Return on Equity:-0.51 
EPS Ratio:3.31 
Revenue:681.0K 
Shares:21.18M 
Market Cap:61.42M 

TECHNICAL INDICATORS

MA5:3.065.4%
MA10:3.179.4%
MA20:3.2712.9%
MA50:3.3314.8%
MA100:3.4117.5%
MA200:3.2411.6%
RSI14:9.09 
WPR14:-100.00 
MTM14:-0.38
ROC14:-0.12 
ATR:0.04 
Week High:3.2311.4%
Week Low:2.900.0%
Month High:3.4820.0%
Month Low:2.9011.6%
Year High:3.9435.9%
Year Low:2.726.6%